Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson's disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Imaging cortical multiple sclerosis lesions with ultra-high field MRI

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Interictal pontine metabolism in migraine without aura patients: A 3 Tesla proton magnetic resonance spectroscopy study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. In vivo tensor-valued diffusion MRI of focal demyelination in white and deep grey matter of rodents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Can topical application of numbing cream improve the efficacy of sham TDCS?

    Publikation: KonferencebidragPosterForskning

  2. Data-driven separation of MRI signal components for tissue characterization

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sensitivity and resolution improvement for in vivo magnetic resonance current-density imaging of the human brain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Parkinson's disease is associated with severe nigro-striatal dopamine depletion, leading to motor dysfunction and altered reward processing. We previously showed that drug-naïve patients with Parkinson's disease had a consistent attenuation of reward signalling in the mesolimbic and mesocortical system. Here, we address the neurobiological effects of dopaminergic therapy on reward sensitivity in the mesolimbic circuitry, and how this may contribute to neuropsychiatric symptoms.

OBJECTIVES: We tested the hypothesis that (1) dopaminergic treatment would restore the attenuated, mesolimbic and mesocortical responses to reward; and (2) restoration of reward responsivity by dopaminergic treatment would predict motor performance and the emergence of impulse control symptoms.

METHODS: In 11 drug-naïve Parkinson patients, we prospectively assessed treatment-induced changes in reward processing before, and eight weeks after initiation of monotherapy with dopamine agonists. They were compared to 10 non-medicated healthy controls who were also measured longitudinally. We used whole-brain functional magnetic resonance imaging at 3 Tesla to assess the reward responsivity of the brain to monetary gains and losses, while participants performed a simple consequential gambling task.

RESULTS: In patients, dopaminergic treatment improved clinical motor symptoms without significantly changing task performance. Dopamine agonist therapy induced a stronger reward responsivity in the right hippocampus with higher doses being less effective. None of the patients developed impulse control disorders in the follow-up period of four years.

CONCLUSIONS: Short-term treatment with first-ever dopaminergic medication partially restores deficient reward-related processing in the hippocampus in de novo Parkinson's disease.

OriginalsprogEngelsk
Artikelnummer102362
TidsskriftNeuroImage. Clinical
Vol/bind28
Sider (fra-til)1-8
Antal sider8
ISSN2213-1582
DOI
StatusUdgivet - 2020

Bibliografisk note

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

ID: 60692752